Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-09

Clinical Trial Update: A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness [NA]

View source ↗

Summary

A double-blind trial comparing scopolamine with cinnarizine to prevent simulator sickness; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cinnarizine (cinnarizine)
  • SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Medical Corps, Israel Defense Force | Conditions: Simulator Sickness | NA | Status: UNKNOWN